GWM
TGTX icon

GK Wealth Management’s TG Therapeutics TGTX Stock Holding History

GK Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.9K Buy
+231
New +$12.5K 0.01% 774

Other funds holding TGTX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
AWM
Avaii Wealth Management Appleton, Wisconsin $348M AUM 25.11% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
NWMP
Noble Wealth Management PBC Greenwood Village, Colorado $223M AUM 7.64% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

GK Wealth Management's TGTX Position: Q3 2026 in Review

GK Wealth Management opened a new position in TG Therapeutics (TGTX) in Q3 2026: 231 shares worth $12.9K. The stake represents 0.01% of the portfolio and ranks #774 among its holdings.

12 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • GK Wealth Management held 231 shares of TG Therapeutics worth $12.9K as of Q3 2026.
  • TG Therapeutics was a new GK Wealth Management position in Q3 2026.
  • TG Therapeutics made up 0.01% of GK Wealth Management's portfolio in Q3 2026, its #774 holding.
  • 12 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.